HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

violamycin BI

RN given refers to cpd with unknown MF; see also violamycins

Also Known As:

violamycin A; violamycin B; violamycin BII

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - violamycin BI: 5

Related Diseases

1.	Cardiotoxicity 02/01/1981 - "Cardiac toxicity of the new anthracycline antitumour antibiotics violamycin BI (V) and carminomycin (C) was studied in comparison with daunorubicin (D). "
2.	Sarcoma 180 01/01/1979 - "Violamycin B, an antibiotic-complex, inhibited the growth of Sarcoma 180 in a well defined manner. "
3.	Neoplasm Metastasis (Metastasis) 01/01/1979 - "[Antineoplastic activity of the anthracycline antibiotic violamycin BI in mice and rats using experimental metastases models (author's transl)]."
4.	Cardiomyopathies (Cardiomyopathy) 02/01/1997 - "Single administration of 2 mg/kg Violamycin B I induces a cardiomyopathy in mice associated with prolongation of the QRS- and S alpha T-segment in the electrocardiogram (ECG). "
5.	Lymphoid Leukemia 01/01/1979 - "The products Violamycin A, BII, and BI obtained by gelfiltration, were tested against the lymphoid Leukemia L1210. "

Related Drugs and Biologics

1.	Anti-Bacterial Agents (Antibiotics)
2.	Anthracyclines
3.	Foscarnet
4.	Zinc
5.	Phosphonoacetic Acid (Phosphonoacetate)
6.	Ions
7.	Daunorubicin (Cerubidine)
8.	Carubicin
9.	Antineoplastic Agents (Antineoplastics)